Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: ILExchange: Nasdaq
DilutionScan read 24 of XTL BIOPHARMACEUTICALS LTD's SEC filings and found 6 warrant series, 1 convertible and 2 completed offerings on file for XTLB. The latest dilution event on file is a warrant issuance on Jun 30, 2026. Analysis updated Oct 5, 2026.
DilutionScan ProEvery instrument in full · $59/mo
Covered companies in Biotechnology. All tickers A to Z
ALZNAlzamend Neuro Inc
SNGXSoligenix, Inc.
APREAprea Therapeutics, Inc.
KPRXKiora Pharmaceuticals, Inc.
TPSTTempest Therapeutics, Inc.
CRISCuris, Inc.
ENSCEnsysce Biosciences, Inc.
VTGNVistaGen Therapeutics, Inc.
IMRNImmuron Limited American Depositary Shares
FBLGFibroBiologics, Inc. Common Stock
MBRXMoleculin Biotech, Inc.
CMMBChemomab Therapeutics Ltd. American Depositary Share
TOVXTheriva Biologics, Inc.
LTRNLantern Pharma Inc.
TCRTAlaunos Therapeutics, Inc.